Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Beringer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Pulmonary Medicine|November 26, 1999
New approaches to optimizing antimicrobial therapy in patients with cystic fibrosisP M Beringer
Current Opinion in Pulmonary Medicine|December 2, 2000
Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical featuresP M Beringer, M D Appleman
The Annals of Pharmacotherapy|March 13, 1998
Predictive performance of a vancomycin-aminoglycoside population modelP M Beringer, A Wong-Beringer, J P Rho
Pharmacoeconomics|December 8, 1997
Economic aspects of antibacterial adverse effectsP M Beringer, A Wong-Beringer, J P Rho
Therapeutic Drug Monitoring|December 29, 2000
Estimation of creatinine clearance in patients with metastatic ovarian cancerM J Montgomery, P M Beringer, S G Louie, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administrationP M Beringer, A A Vinks, R W Jelliffe, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2022
Physiologically Based Pharmacokinetic Modeling To Guide Management of Drug Interactions between Elexacaftor-Tezacaftor-Ivacaftor and Antibiotics for the Treatment of Nontuberculous MycobacteriaE Hong, L M Almond, P S Chung, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2002
Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosisA Aminimanizani, P M Beringer, J Kang, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosisM J Montgomery, P M Beringer, A Aminimanizani, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Pulmonary Medicine|November 26, 1999
New approaches to optimizing antimicrobial therapy in patients with cystic fibrosisP M Beringer
Current Opinion in Pulmonary Medicine|December 2, 2000
Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical featuresP M Beringer, M D Appleman
The Annals of Pharmacotherapy|March 13, 1998
Predictive performance of a vancomycin-aminoglycoside population modelP M Beringer, A Wong-Beringer, J P Rho
Pharmacoeconomics|December 8, 1997
Economic aspects of antibacterial adverse effectsP M Beringer, A Wong-Beringer, J P Rho
Therapeutic Drug Monitoring|December 29, 2000
Estimation of creatinine clearance in patients with metastatic ovarian cancerM J Montgomery, P M Beringer, S G Louie, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administrationP M Beringer, A A Vinks, R W Jelliffe, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2022
Physiologically Based Pharmacokinetic Modeling To Guide Management of Drug Interactions between Elexacaftor-Tezacaftor-Ivacaftor and Antibiotics for the Treatment of Nontuberculous MycobacteriaE Hong, L M Almond, P S Chung, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2002
Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosisA Aminimanizani, P M Beringer, J Kang, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosisM J Montgomery, P M Beringer, A Aminimanizani, et al.
Pageof 1